Revolution Medicines Inc (NAS:RVMDW)
$ 0.5382 -0.0718 (-11.77%) Market Cap: - Enterprise Value: - PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 41/100

Q2 2021 Revolution Medicines Inc Earnings Call Transcript

Aug 11, 2021 / 08:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Revolution Medicines Second Quarter Fiscal 2021 Financial Results Conference Call and Webcast. (Operator Instructions). Please be advised that today's conference call is being recorded. (Operator Instructions)

I would now like to hand the conference over to Peg Horn, Revolution's Chief Operating Officer for opening remarks. Peg, you may begin.

Margaret A. Horn
Revolution Medicines, Inc. - COO, General Counsel & Secretary

Good afternoon, everyone, and thank you all for joining us today. Joining me on today's call are Dr. Mark Goldsmith, Revolution's Chairman and Chief Executive Officer; Dr. Steve Kelsey, the company's President, Research & Development; and Jack Anders, our Senior Vice President of Finance and Principal Accounting Officer.

As we begin, I'd like to caution you that our presentation today will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act regarding the current beliefs of the company with respect to our business.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot